KNIGHT CAPITOL CONSULTANTS for EQUASHIELD, LLC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
Efforts to ensure worker safety in the administration of hazardous chemicals (no specific legislation).
Foreign entity interest: Equashield Medical, LTD is the parent company of Equashield, LLC
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch; Health Policy Director, Senator Orrin G. Hatch |
Taxation/Internal Revenue Code TAX
Legislation to repeal the 2.3%$ excise tax on medical devices, the Protect Medical Innovation act of 2019 (S. 692 contained in the Further Consolidated Appropriations Act, PL 116-94)
Foreign entity interest: Equashield Medical, LTD is the parent company of Equashield, LLC
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch 1999-2008 |
Pharmacy PHA
Vial reuse provisions of the Prescription Drug Pricing Reduction Act of 2019 (S. 2543)
Foreign entity interest: Equashield Medical, LTD is the parent company of Equashield, LLC
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.